This allowed the metastatic carcinoma patients individuation with accuracy between 84% and 96% and identified surrogate signatures of spliced RNAs, associated with the molecular subtype of the tumor tissue, such as EGFR and KRAS mutations and HER2 and MET amplification [67]. The gene discussed is EGFR; the disease is neoplasm.